Ocrelizumab 67643-7001
Product NDC
67643-7001- Manufacturer
- Lonza Biologics, Inc.
- Dosage Form
- Liquid
- Product Type
- Drug For Further Processing
- Marketing Start
- June 30, 2025
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ocrelizumab | 55 g/L |
Packaging Options(1)
300 L in 1 TANK (67643-7001-1)